Dr. Paul La Porte
Claim this profileGSK Investigational Site
Studies Non-Small Cell Lung Cancer
Studies Breast Cancer
10 reported clinical trials
18 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
NRG1 positive
2Breast Cancer
metastatic
ER
HER2
Affiliated Hospitals
Clinical Trials Paul La Porte is currently running
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial. The phase 1b part of the trial aims to determine the RP2D of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, abemaciclib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in patients with ER+/HER2- advanced/metastatic breast cancer.
Recruiting1 award Phase 1 & 2
Zenocutuzumab
for Non-Small Cell Lung and Prostate Cancers
This is a Phase II, open-label, 2-arm, multicenter, international study designed to evaluate the efficacy of zenocutuzumab alone or in combination in patients with the following diagnoses: Group A: NRG1+ NSCLC Group B: mCRPC
Recruiting1 award Phase 2
More about Paul La Porte
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Paul La Porte has experience with
- TSR-022
- Zenocutuzumab
- Dostarlimab
- Cobolimab
- Docetaxel
- Enobosarm
Breakdown of trials Paul La Porte has run
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul La Porte specialize in?
Paul La Porte focuses on Non-Small Cell Lung Cancer and Breast Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Paul La Porte currently recruiting for clinical trials?
Yes, Paul La Porte is currently recruiting for 5 clinical trials in Whittier California. If you're interested in participating, you should apply.
Are there any treatments that Paul La Porte has studied deeply?
Yes, Paul La Porte has studied treatments such as TSR-022, Zenocutuzumab, Dostarlimab.
What is the best way to schedule an appointment with Paul La Porte?
Apply for one of the trials that Paul La Porte is conducting.
What is the office address of Paul La Porte?
The office of Paul La Porte is located at: GSK Investigational Site, Whittier, California 90603 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.